Self-administration of Rozanolixizumab in Patients with Generalized Myasthenia Gravis: The MG0020 Study (P1-11.018)
To assess successful self-administration, efficacy and safety of rozanolixizumab using manual push (MP) and syringe driver (SD) methods in patients with generalized myasthenia gravis (gMG).
Authors
- Artur Drużdż (ORCID: https://orcid.org/0009-0008-6502-2952)
- Carlo Antozzi (ORCID: https://orcid.org/0000-0001-9270-5224)
- Tomasz Berkowicz
- Maria Isabel Leite (ORCID: https://orcid.org/0000-0002-4277-9855)
- Rachana Gandhi (ORCID: https://orcid.org/0000-0003-0185-8618)
- M. Morris (ORCID: https://orcid.org/0000-0002-6753-2066)
- Pradeep Kumar Singh (ORCID: https://orcid.org/0000-0002-8312-9277)
- Marion Boehnlein
- Vera Bril (ORCID: https://orcid.org/0000-0002-5805-4883)
- Zabeen Mahuwala
- Jana Zschüntzsch (ORCID: https://orcid.org/0000-0002-7062-5319)
- Andreea Lavrov
Institutions
- University Health Network (CA)
- University of Kentucky (US)
- University of Oxford (GB)
- Universitätsmedizin Göttingen (DE)
- Fondazione IRCCS Istituto Neurologico Carlo Besta (IT)
- UCB Pharma (Germany) (DE)
- Wake Forest University (US)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000208796
- Primary Topic
- Myasthenia Gravis and Thymoma
- Type
- article
- Field-Weighted Citation Impact
- 0.00